← Browse by Condition
Medical Condition
recurrence
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT06087068 Phase 2
Recruiting
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
Enrollment
140 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT05861505 Phase 3
Recruiting
COLLISION RELAPSE Trial
Enrollment
360 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc